• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Combining stable insect cell lines with baculovirus-mediated expression for multi-HA influenza VLP production

tetano

Editor, Senior Moderator
Vaccine. 2017 Mar 10. pii: S0264-410X(17)30246-3. doi: 10.1016/j.vaccine.2017.02.043. [Epub ahead of print]
[h=1]Combining stable insect cell lines with baculovirus-mediated expression for multi-HA influenza VLP production.[/h] Sequeira DP[SUP]1[/SUP], Correia R[SUP]1[/SUP], Carrondo MJ[SUP]2[/SUP], Rold?o A[SUP]3[/SUP], Teixeira AP[SUP]4[/SUP], Alves PM[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Safer and broadly protective vaccines are needed to cope with the continuous evolution of circulating influenza virus strains and promising approaches based on the expression of multiple hemagglutinins (HA) in a virus-like particle (VLP) have been proposed. However, expression of multiple genes in the same vector can lead to its instability due to tandem repetition of similar sequences. By combining stable with transient expression systems we can rationally distribute the number of genes to be expressed per platform and thus mitigate this risk. In this work, we developed a modular system comprising stable and baculovirus-mediated expression in insect cells for production of multi-HA influenza enveloped VLPs. First, a stable insect High Five cell population expressing two different HA proteins from subtype H3 was established. Infection of this cell population with a baculovirus vector encoding three other HA proteins from H3 subtype proved to be as competitive as traditional co-infection approaches in producing a pentavalent H3 VLP. Aiming at increasing HA expression, the stable insect cell population was infected at increasingly higher cell concentrations (CCI). However, cultures infected at CCI of 3?10[SUP]6[/SUP]cells/mL showed lower HA titers per cell in comparison to standard CCI of 2?10[SUP]6[/SUP]cells/mL, a phenomenon named "cell density effect". To lessen the negative impact of this phenomenon, a tailor-made refeed strategy was designed based on the exhaustion of key nutrients during cell growth. Noteworthy, cultures supplemented and infected at a CCI of 4?10[SUP]6[/SUP]cells/mL showed comparable HA titers per cell to those of CCI of 2?10[SUP]6[/SUP]cells/mL, thus leading to an increase of up to 4-fold in HA titers per mL. Scalability of the modular strategy herein proposed was successfully demonstrated in 2L stirred tank bioreactors with comparable HA protein levels observed between bioreactor and shake flasks cultures. Overall, this work demonstrates the suitability of combining stable with baculovirus-mediated expression in insect cells as an efficient platform for production of multi-HA influenza VLPs, surpassing the drawbacks of traditional co-infection strategies and/or the use of larger, unstable vectors.
Copyright ? 2017 Elsevier Ltd. All rights reserved.


[h=4]KEYWORDS:[/h] Bioprocess optimization; Hemagglutinin-based vaccine; Modular strategy; Multivalent influenza virus-like particles; Scale-up; Stable insect cells

PMID: 28291648 DOI: 10.1016/j.vaccine.2017.02.043
 
Back
Top Bottom